시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 신경인지 평가 및 재활 시장 보고서(2025년)
Neurocognitive Assessment And Rehabilitation Global Market Report 2025
상품코드 : 1825832
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

신경인지 평가 및 재활 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년 연평균 성장률(CAGR)은 8.8%로 2029년 205억 4,000만 달러로 성장할 것입니다. 예측 기간의 성장은 개인화된 의료 접근 방식, 기업 웰니스 프로그램, 기술 발전, 보험 적용 및 상환 개선, 원격의료와의 통합에 기인합니다. 예측 기간의 주요 동향으로는 웨어러블 기술 도입, 재생의료, 신경가소성 연구, 맞춤형 재활 프로그램, 가상현실(VR) 및 증강현실(AR) 활용, 다학제적 접근법 등이 있습니다.

향후 5년간 8.8%의 성장률 전망은 지난번 예측보다 0.5% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 무역 마찰은 핀란드와 일본에서 개발된 컴퓨터 인지 검사 시스템이나 가상현실 재활 플랫폼의 가격을 급등시키고, 치료 시작 지연과 신경심리 서비스 요금 상승을 초래하여 미국의 뇌손상 회복을 방해할 수 있습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

신경질환의 유병률 증가는 당분간 신경인지 평가 및 재활치료 시장의 성장을 견인할 것으로 예상됩니다. 신경질환은 뇌, 척수, 신경 등 신경계에 영향을 미치는 병을 포함하며 근력저하, 협응운동장애, 인지장애 등의 증상을 유발하는 경우가 많습니다. 이러한 장애는 고령화, 알츠하이머병이나 파킨슨병과 같은 노화 관련 질환의 발생률 증가 등 다양한 요인이 복합적으로 작용하여 발생합니다. 신경인지기능 평가는 인지기능을 평가하고 신경질환의 진단과 치료 계획을 수립하는 데 중요한 역할을 합니다. 한편, 재활 중재는 신경 기능을 최적화하고 표적화된 치료와 전략을 통해 삶의 질을 향상시키는 것을 목표로 합니다. 예를 들어, 미국 알츠하이머병 협회(Alzheimer's Association)의 자료에 따르면, 미국 내 85세 이상 알츠하이머병 유병률은 2024년 240만 명에 달하고, 2060년에는 670만 명까지 증가할 것으로 예측하고 있습니다. 따라서 신경 질환의 유병률 증가는 신경인지 평가 및 재활 시장 확대의 주요 촉진요인으로 작용하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSM
영문 목차

영문목차

Neurocognitive rehabilitation entails therapeutic interventions aimed at diagnosing and addressing cognitive impairments stemming from neurological conditions, brain injuries, or psychological disorders. It encompasses a series of standardized tests and clinical assessments devised to gauge cognitive functions such as memory, attention, language, and problem-solving abilities.

The principal components of neurocognitive assessment and rehabilitation comprise neurocognitive assessment testing and neurorehabilitation therapy. Neurocognitive assessment testing involves evaluating an individual's cognitive functions-such as memory, attention, and problem-solving skills-to assess brain health and identify any impairments or disorders. Providers of these services include rehabilitation centers, hospitals, clinics, home care settings, and physiotherapy centers, catering to organizations ranging from large enterprises to small and medium-sized enterprises (SMEs).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The neurocognitive assessment and rehabilitation market research report is one of a series of new reports from The Business Research Company that provides neurocognitive assessment and rehabilitation market statistics, including the neurocognitive assessment and rehabilitation industry global market size, regional shares, competitors with neurocognitive assessment and rehabilitation market share, detailed neurocognitive assessment and rehabilitation market segments, market trends, and opportunities, and any further data you may need to thrive in the neurocognitive assessment and rehabilitation industry. These neurocognitive assessment and rehabilitation market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The neurocognitive assessment and rehabilitation market size has grown strongly in recent years. It will grow from $13.4 billion in 2024 to $14.65 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to an increased incidence of neurocognitive disorders, an aging population, increased awareness, and education, healthcare policy and funding, improved diagnostic techniques, and a rise in mental health issues.

The neurocognitive assessment and rehabilitation market size is expected to see strong growth in the next few years. It will grow to $20.54 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to personalized medicine approaches, corporate wellness programs, technological advancements, insurance coverage and reimbursement improvements, and integration with telehealth. Major trends in the forecast period include wearable technology adoption, regenerative medicine, and neuroplasticity research, personalized rehabilitation programs, virtual reality (VR) and augmented reality (AR) utilization, and interdisciplinary approaches.

The forecast of 8.8% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. brain injury recovery by inflating prices of computerized cognitive testing systems and Virtual Reality rehabilitation platforms developed in Finland and Japan, resulting in delayed therapy initiation and higher neuropsychology service fees. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rise in the prevalence of neurological disorders is anticipated to drive the expansion of the neurocognitive assessment and rehabilitation market in the foreseeable future. Neurological disorders encompass medical conditions affecting the nervous system, including the brain, spinal cord, and nerves, often resulting in symptoms such as muscle weakness, coordination difficulties, and cognitive deficits. These disorders arise from a combination of factors, including an aging demographic and the increased incidence of age-related conditions such as Alzheimer's disease and Parkinson's disease. Neurocognitive assessment plays a crucial role in evaluating cognitive function, facilitating diagnosis and treatment planning for neurological disorders, while rehabilitation interventions aim to optimize neural functioning and improve quality of life through targeted therapies and strategies. For instance, data from the Alzheimer's Association, a US-based health organization, suggests that the prevalence of Alzheimer's dementia in individuals aged 85 and older in the US is projected to reach 2.4 million in 2024 and is expected to further increase to 6.7 million by 2060. Hence, the growing prevalence of neurological disorders is a key driver for the expansion of the neurocognitive assessment and rehabilitation market.

Major players in the neurocognitive assessment and rehabilitation market are innovating by developing advanced solutions, such as digital tests, to screen for cognitive impairment and gain a competitive advantage. Digital tests involve assessments conducted through digital platforms or software to evaluate various cognitive functions, including memory, attention, language, and executive function. For example, Neurotrack Technologies, a US-based company specializing in web-based screening tools and cognitive health programs, introduced a 3-minute digital test in November 2022 to screen for cognitive impairment. This tool enables primary care teams to efficiently screen for cognitive decline during annual wellness visits, facilitating early detection of neurodegenerative diseases such as Alzheimer's. With culturally-agnostic features enhancing accuracy and accessibility, this innovative solution addresses the critical need for cognitive screening in an aging population. It empowers healthcare providers to seamlessly integrate cognitive testing into clinical workflows, potentially revolutionizing dementia care and intervention strategies.

In September 2023, Enlyte Group LLC, a US-based software company, acquired Therapy Direct LLC from Upstream Rehabilitation for an undisclosed sum. This acquisition is aimed at bolstering Enlyte's clinical services and network offerings, demonstrating a commitment to delivering high-quality casualty solutions and services to meet evolving customer demands. Therapy Direct, a US-based subsidiary of Upstream Rehabilitation Inc., specializes in providing medical rehabilitation services, particularly physical therapy.

Major companies operating in the neurocognitive assessment and rehabilitation market are Cogstate Ltd, Posit Science Corporation, Lumos Labs Inc., The Magstim Company Ltd, MindMaze SA, CogniFit Inc, Cambridge Cognition Holdings plc, ImPACT Applications Inc., Neurotrack Technologies Inc., Neuroelectrics Corporation, SCHUHFRIED GmbH, Constant Therapy Health Inc., NeuronUP S.L., Qbtech AB, Neurometrix Inc., CogniVue Corporation, Neurohealth Associates LLP, BrainTrain Inc., NeuroEM Therapeutics Inc., HASOMED GmbH, Neurosoft Bioelectronics Corporation, AnthroTronix Inc., Flow Neuroscience AB, NPsych Limited

North America was the largest region in the neurocognitive assessment and rehabilitation market in 2024. The regions covered in the neurocognitive assessment and rehabilitation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the neurocognitive assessment and rehabilitation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The neurocognitive assessment and rehabilitation market consists of revenues earned by entities by providing services for individualized rehabilitation planning, cognitive training, psychoeducation, and counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The neurocognitive assessment and rehabilitation market also includes sales of software applications, wearable devices, virtual reality systems, brain stimulation devices, and specialized exercise equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neurocognitive Assessment And Rehabilitation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neurocognitive assessment and rehabilitation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for neurocognitive assessment and rehabilitation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neurocognitive assessment and rehabilitation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Neurocognitive Assessment And Rehabilitation Market Characteristics

3. Neurocognitive Assessment And Rehabilitation Market Trends And Strategies

4. Neurocognitive Assessment And Rehabilitation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Neurocognitive Assessment And Rehabilitation Growth Analysis And Strategic Analysis Framework

6. Neurocognitive Assessment And Rehabilitation Market Segmentation

7. Neurocognitive Assessment And Rehabilitation Market Regional And Country Analysis

8. Asia-Pacific Neurocognitive Assessment And Rehabilitation Market

9. China Neurocognitive Assessment And Rehabilitation Market

10. India Neurocognitive Assessment And Rehabilitation Market

11. Japan Neurocognitive Assessment And Rehabilitation Market

12. Australia Neurocognitive Assessment And Rehabilitation Market

13. Indonesia Neurocognitive Assessment And Rehabilitation Market

14. South Korea Neurocognitive Assessment And Rehabilitation Market

15. Western Europe Neurocognitive Assessment And Rehabilitation Market

16. UK Neurocognitive Assessment And Rehabilitation Market

17. Germany Neurocognitive Assessment And Rehabilitation Market

18. France Neurocognitive Assessment And Rehabilitation Market

19. Italy Neurocognitive Assessment And Rehabilitation Market

20. Spain Neurocognitive Assessment And Rehabilitation Market

21. Eastern Europe Neurocognitive Assessment And Rehabilitation Market

22. Russia Neurocognitive Assessment And Rehabilitation Market

23. North America Neurocognitive Assessment And Rehabilitation Market

24. USA Neurocognitive Assessment And Rehabilitation Market

25. Canada Neurocognitive Assessment And Rehabilitation Market

26. South America Neurocognitive Assessment And Rehabilitation Market

27. Brazil Neurocognitive Assessment And Rehabilitation Market

28. Middle East Neurocognitive Assessment And Rehabilitation Market

29. Africa Neurocognitive Assessment And Rehabilitation Market

30. Neurocognitive Assessment And Rehabilitation Market Competitive Landscape And Company Profiles

31. Neurocognitive Assessment And Rehabilitation Market Other Major And Innovative Companies

32. Global Neurocognitive Assessment And Rehabilitation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neurocognitive Assessment And Rehabilitation Market

34. Recent Developments In The Neurocognitive Assessment And Rehabilitation Market

35. Neurocognitive Assessment And Rehabilitation Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기